Title:
がんの組み合わせ治療
Document Type and Number:
Japanese Patent JP2023553257
Kind Code:
A
Abstract:
本開示は、がんの治療に有用な組み合わせ療法に関する。特に、本開示は、がんを治療するためのＰＤ－１阻害剤、ＴＧＦベータ阻害剤、及びＭＣＴ４阻害剤の併用に関する。
Inventors:
Ada Zara-Hojeman
Frank Chowderna
ralph lindemann
Roberta Ferretti
Shivapriya Ramaswamy
Frank Chowderna
ralph lindemann
Roberta Ferretti
Shivapriya Ramaswamy
Application Number:
JP2023526624A
Publication Date:
December 21, 2023
Filing Date:
November 01, 2021
Export Citation:
Assignee:
Ares Trading Society Anonym
GlaxoSmithKline Intellectual Property (Number 4) Limited
GlaxoSmithKline Intellectual Property (Number 4) Limited
International Classes:
A61K45/06; A61K9/08; A61K9/14; A61K9/20; A61K9/48; A61K31/12; A61K31/196; A61K31/343; A61K31/352; A61K31/381; A61K31/403; A61K31/416; A61K31/428; A61K31/433; A61K31/44; A61K31/47; A61K31/4709; A61K31/4745; A61K31/498; A61K31/5377; A61K39/395; A61P35/00; A61P35/02; A61P43/00; C07K14/705; C07K16/18; C07K19/00
Attorney, Agent or Firm:
Atsushi Aoki
Shinji Mihashi
Youichi Watanabe
Nakajima Masaru
Tatsunori Ikeda
Shinji Mihashi
Youichi Watanabe
Nakajima Masaru
Tatsunori Ikeda
Previous Patent: Additive automatic dosing module and washing machine
Next Patent: austenitic stainless steel
Next Patent: austenitic stainless steel